MetLife Investment Management
ALT icon

MetLife Investment Management’s Altimmune ALT Stock Holding History

MetLife Investment Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
116,856
+44,643
+62% +$133K ﹤0.01% 2105
2026
Q1 		$222K Buy
72,213
+34,020
+89% +$144K ﹤0.01% 2176
2025
Q4 		$138K Sell
38,193
-6,341
-14% -$27.6K ﹤0.01% 2458
2025
Q3 		$168K Sell
44,534
-2,336
-5% -$9.02K ﹤0.01% 2414
2025
Q2 		$181K Hold
46,870
– – ﹤0.01% 2246
2025
Q1 		$234K Buy
46,870
+2,396
+5% +$15.2K ﹤0.01% 2116
2024
Q4 		$321K Buy
44,474
+2,897
+7% +$22.1K ﹤0.01% 2035
2024
Q3 		$255K Hold
41,577
– – ﹤0.01% 2158
2024
Q2 		$276K Buy
41,577
+15,262
+58% +$113K ﹤0.01% 2044
2024
Q1 		$268K Hold
26,315
– – ﹤0.01% 2028
2023
Q4 		$296K Hold
26,315
– – ﹤0.01% 2012
2023
Q3 		$68.4K Hold
26,315
– – ﹤0.01% 2770
2023
Q2 		$92.9K Buy
+26,315
New +$118K ﹤0.01% 2723
2022
Q2 		– Sell
-21,184
Closed -$129K – 2857
2022
Q1 		$129K Buy
21,184
+8,385
+66% +$61.8K ﹤0.01% 2569
2021
Q4 		$117K Hold
12,799
– – ﹤0.01% 2351
2021
Q3 		$145K Hold
12,799
– – ﹤0.01% 2268
2021
Q2 		$126K Buy
+12,799
New +$175K ﹤0.01% 2383

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's ALT Position: Q2 2026 in Review

MetLife Investment Management increased its Altimmune (ALT) stake by 62% in Q2 2026, buying an estimated $133K and bringing the position to 116,856 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

MetLife Investment Management first reported a position in ALT in Q2 2021 and has held it in 17 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • MetLife Investment Management held 116,856 shares of Altimmune worth $355K as of Q2 2026.
  • MetLife Investment Management bought 44,643 Altimmune shares in Q2 2026, an estimated $133K.
  • Altimmune made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2105 holding.
  • MetLife Investment Management first reported a position in Altimmune in Q2 2021 and has held it in 17 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.